Exosens Stock Surpasses +108% in One Year, Targeting Key Resistance at €72.90
Exosens stock is trading at €66.55 this Tuesday mid-session, up 2.07% from the previous day's close. This increase extends a remarkable trend, with a gain of over 12% in the past seven days and an annual performance now exceeding 108%.
This Tuesday, Exosens stock is significantly above its 50-day moving average, which is at €60.46, and even more so above its 200-day moving average, which stands at €48.26. This increasing gap indicates a strong underlying bullish movement that has accelerated in recent weeks, with the stock price increasing by 25.8% over three months. The RSI, a momentum indicator, is at 54: a neutral level that signals neither overbuying nor exhaustion of the movement, leaving room before reaching an overbought zone. The stock is currently fluctuating between the Bollinger bands, with the upper bound at €74.32 and the lower bound at €56.31. The identified resistance level at €72.90 is the next technical threshold to watch, while the major support is positioned at €55.60. The monthly volatility remains contained at 13.48%, suggesting a relatively steady progression of the stock in the recent period.
Upcoming Catalysts for Exosens
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
The next identified catalyst for Exosens is the publication of its first quarter 2026 results, scheduled for April 27. This event could be a crucial test for the stock, whose valuation has more than doubled in a year. The general meeting is scheduled for May 22, followed by the semi-annual results expected on July 28. In a generally buoyant Parisian market this Tuesday, with the CAC 40 up 1.33% at 8,068 points during the session, Exosens is moving in the same direction as the French index. However, disparities are noted among European technology stocks: ASML is down 3.03% while Schneider Electric is up 1.19%. The negative beta of the stock (?0.14) indicates a very low correlation with the overall market, suggesting that Exosens' dynamics are primarily driven by company-specific factors rather than general market movements.
Nous sommes fiers de présenter notre performance sur les neuf premiers mois de l’année 2025, qui témoignent d'une croissance soutenue du chiffre d'affaires et de la marge brute ajustée, portée par la forte dynamique du secteur de la Défense.
Marché de la Défense très dynamique, forte demande pour la vision nocturne et les systèmes pour drones/anti-drones, croissance soutenue en Europe avec contribution des États-Unis et de l’Asie-Pacifique. Lancement commercial réussi des tubes 5G (plus de 5 000 commandes avant lancement).
Risks mentioned
Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
Dépendance aux budgets de Défense et aux évolutions géopolitiques
Risque d'intégration des acquisitions récentes
Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Opportunities identified
Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.